Wolverine Asset Management’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-203,600
Closed -$1.84M 1501
2019
Q4
$1.84M Sell
203,600
-96,400
-32% -$783K 0.02% 459
2019
Q3
$2.16M Buy
+300,000
New +$2.15M 0.03% 397
2017
Q4
Sell
-202,500
Closed -$3.6M 1492
2017
Q3
$3.6M Buy
+202,500
New +$4.17M 0.04% 319

Other funds holding EVH

Wolverine Asset Management's EVH Position: Q1 2026 in Review

Wolverine Asset Management sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 487 shares — an estimated $1.95K sold.

Wolverine Asset Management first reported a position in EVH in Q2 2017 and held it in 8 quarters. The position peaked at $2.22M in Q2 2019. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Wolverine Asset Management reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
  • Wolverine Asset Management sold 487 Evolent Health shares in Q1 2026, an estimated $1.95K.
  • Wolverine Asset Management first reported a position in Evolent Health in Q2 2017 and held it in 8 quarters.
  • Wolverine Asset Management's Evolent Health position peaked at $2.22M in Q2 2019.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Wolverine Asset Management's 13F filing for Q1 2026, filed 4 May 2026.